Catalyst Wire Dossier Catalyst Wire Dossier

MEDI3902

MEDI3902 · MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI3902, covering 2018-08-13 to 2018-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults [Phase 1]

See pricing